Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma
Open Access
- 28 October 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 590
- https://doi.org/10.1186/1471-2407-10-590
Abstract
Background: Lung cancer remains the leading cause of cancer-related mortality despite continuous efforts to find effective treatments. Data from the American Cancer Society indicate that while the overall incidence of lung cancer is declining, it continues to rise in women. Stem cell-based therapy has been an emerging strategy to treat various diseases. The purpose of this paper is to determine the efficacy of an intrinsic anti-cancer effect of rat umbilical cord matrix stem cells (UCMSCs) on lung cancer.Methods: A mouse syngeneic lung carcinoma model was used to test the basic ability of UCMSCs to control the growth of lung cancer. Lung tumors were experimentally induced by tail vein administration of Lewis lung carcinoma (LLC) cells derived from the lung of C57BL/6 mouse. Rat UCMSCs were then administered intratracheally five days later or intravenously on days 5 and 7. The tumor burdens were determined by measuring lung weight three weeks after the treatment.Results: Co-culture of rat UCMSCs with LLC significantly attenuated the proliferation of LLC cells as monitored by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), a tetrazole cell proliferation assay, thymidine uptake, and direct cell counts.In vitrocolony assays with rat UCMSCs as feeder layers markedly reduced LLC colony size and number. Co-culture of rat UCMSCs with LLCs causes G0/G1 arrest of cancer cells. This is evident in the decrease of cyclin A and CDK2 expression. Thein vivostudies showed that rat UCMSC treatment significantly decreased tumor weight and the total tumor mass. Histological study revealed that intratracheally or systemically administered rat UCMSCs homed to tumor areas and survived for at least 3 weeks without any evidence of differentiation or adverse effects.Conclusions: These results indicate that rat UCMSCs alone remarkably attenuate the growth of lung carcinoma cellsin vitroand in a mouse syngeneic lung carcinoma graft model and could be used for targeted cytotherapy for lung cancer.Keywords
This publication has 24 references indexed in Scilit:
- Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivoCancer Letters, 2009
- Rat Umbilical Cord Stem Cells Completely Abolish Rat Mammary Carcinomas with No Evidence of Metastasis or Recurrence 100 Days Post–Tumor Cell InoculationCancer Research, 2009
- Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived CellsThe International Journal of Cell Cloning, 2008
- Detection of migration of locally implanted AC133 + stem cells by cellular magnetic resonance imaging with histological findingsThe FASEB Journal, 2008
- Therapeutic potential of genetically modified mesenchymal stem cellsGene Therapy, 2008
- Immunogenicity of umbilical cord tissue–derived cellsBlood, 2008
- Mesenchymal stem cells within tumour stroma promote breast cancer metastasisNature, 2007
- Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaThe Journal of Experimental Medicine, 2006
- Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's DiseaseThe International Journal of Cell Cloning, 2005
- Novel Agents in the Treatment of Lung CancerClinical Cancer Research, 2004